DK1456360T3
(en)
*
|
2001-04-19 |
2015-08-31 |
Scripps Research Inst |
Methods and Composition for Preparation of Orthogonal TRNA-Aminoacyl-TRNA Synthetase Pairs
|
WO2004035605A2
(en)
*
|
2002-10-16 |
2004-04-29 |
The Scripps Research Institute |
Glycoprotein synthesis
|
JP5642916B2
(ja)
|
2003-04-17 |
2014-12-17 |
ザ スクリプス リサーチ インスティテュート |
真核遺伝コードの拡張
|
CN102618605B
(zh)
|
2003-06-18 |
2015-09-02 |
斯克利普斯研究院 |
非天然活性氨基酸遗传密码增加
|
EP1649004A4
(de)
*
|
2003-07-07 |
2008-04-09 |
Scripps Research Inst |
Zusammensetzungen mit paaren von orthogonaler lysyl-trna und aminoacyl-trna-synthetase und verwendungen davon
|
DK1687401T3
(da)
|
2003-10-14 |
2013-02-04 |
Scripps Research Inst |
Sted-spicifik inkorporing af redoxaktive aminosyrer i protiener
|
GB2429207A
(en)
|
2004-02-02 |
2007-02-21 |
Ambrx Inc |
Modified human interferon polypeptides and their uses
|
AU2005319099B2
(en)
|
2004-02-02 |
2010-09-16 |
Ambrx, Inc. |
Modified human growth hormone
|
EP1774018A2
(de)
*
|
2004-05-25 |
2007-04-18 |
The Scripps Research Institute |
Ortsspezifische inkorporation von schweratomhaltigen unnatürlichen aminosäuren in proteine zur kristallstrukturbestimmung
|
KR101699142B1
(ko)
|
2004-06-18 |
2017-01-23 |
암브룩스, 인코포레이티드 |
신규 항원-결합 폴리펩티드 및 이의 용도
|
JP2008513039A
(ja)
|
2004-09-21 |
2008-05-01 |
ザ スクリップス リサーチ インスティテュート |
真正細菌の蛋白質へのアルキニルアミノ酸のインビボ組込み
|
JP2008513806A
(ja)
*
|
2004-09-22 |
2008-05-01 |
ザ スクリップス リサーチ インスティテュート |
Nmr試験のための蛋白質の部位特異的標識
|
EP1809758A4
(de)
|
2004-10-20 |
2009-04-01 |
Scripps Research Inst |
Stellenspezifischer in-vivo-einbau von n-acetylgalactosamin-aminosäuren in eubakterien
|
US8216804B2
(en)
|
2004-10-27 |
2012-07-10 |
The Scripps Research Institute |
Orthogonal translation components for the in vivo incorporation of unnatural amino acids
|
US8080391B2
(en)
|
2004-12-22 |
2011-12-20 |
Ambrx, Inc. |
Process of producing non-naturally encoded amino acid containing high conjugated to a water soluble polymer
|
US7816320B2
(en)
|
2004-12-22 |
2010-10-19 |
Ambrx, Inc. |
Formulations of human growth hormone comprising a non-naturally encoded amino acid at position 35
|
EP1836298B1
(de)
|
2004-12-22 |
2012-01-18 |
Ambrx, Inc. |
Zusammensetzungen von aminoacyl-trna-synthetase und verwendungen davon
|
ATE529442T1
(de)
|
2005-06-03 |
2011-11-15 |
Ambrx Inc |
Verbesserte humane interferon-moleküle und ihre verwendungen
|
RU2459866C2
(ru)
*
|
2005-10-12 |
2012-08-27 |
Зе Скрипс Ресеч Инститьют |
Селективная посттрансляционная модификация экспонируемых фагами полипептидов
|
PT2339014E
(pt)
|
2005-11-16 |
2015-10-13 |
Ambrx Inc |
Métodos e composições compreendendo aminoácidos não-naturais
|
CA2633524A1
(en)
|
2005-12-22 |
2007-07-05 |
Pacific Biosciences Of California, Inc. |
Polymerases for nucleotide analogue incorporation
|
AU2007223830A1
(en)
|
2006-03-09 |
2007-09-13 |
The Scripps Research Institute |
System for the expression of orthogonal translation components in eubacterial host cells
|
US8217145B2
(en)
*
|
2006-03-16 |
2012-07-10 |
The Scrips Research Institute |
Genetically programmed expression of proteins containing the unnatural amino acid phenylselenocysteine
|
AU2007267950B2
(en)
*
|
2006-05-23 |
2012-08-16 |
The Scripps Research Institute |
Genetically encoded fluorescent coumarin amino acids
|
WO2008030614A2
(en)
|
2006-09-08 |
2008-03-13 |
Ambrx, Inc. |
Suppressor trna transcription in vertebrate cells
|
DK2615108T3
(en)
|
2006-09-08 |
2017-01-30 |
Ambrx Inc |
Modified human plasma polypeptide or fc scaffolds and their applications
|
US8114652B2
(en)
*
|
2006-09-21 |
2012-02-14 |
The Scripps Research Institute |
Genetically programmed expression of selectively sulfated proteins in eubacteria
|
WO2008073184A2
(en)
|
2006-10-18 |
2008-06-19 |
The Scripps Research Institute |
Genetic incorporation of unnatural amino acids into proteins in mammalian cells
|
KR20140012199A
(ko)
|
2007-03-30 |
2014-01-29 |
암브룩스, 인코포레이티드 |
변형된 fgf-21 폴리펩티드 및 그 용도
|
CN103965347B
(zh)
|
2007-05-02 |
2017-07-18 |
Ambrx公司 |
经修饰干扰素β多肽和其用途
|
CA2703736A1
(en)
*
|
2007-10-25 |
2009-04-30 |
The Scripps Research Institute |
Genetic incorporation of 3-aminotyrosine into reductases
|
WO2009059056A2
(en)
*
|
2007-11-02 |
2009-05-07 |
The Scripps Research Institute |
A genetically encoded boronate amino acid
|
CA2704494A1
(en)
*
|
2007-11-02 |
2009-05-14 |
The Scripps Research Institute |
Directed evolution using proteins comprising unnatural amino acids
|
AU2008326324B9
(en)
|
2007-11-20 |
2012-11-15 |
Ambrx, Inc. |
Modified insulin polypeptides and their uses
|
EP2889370A1
(de)
*
|
2007-12-11 |
2015-07-01 |
The Scripps Research Institute |
Unnatürliche In-vivo-Aminosäure-Expression bei der Methylotrophen-Hefe Pichia pastoris
|
EP3103880A1
(de)
|
2008-02-08 |
2016-12-14 |
Ambrx, Inc. |
Modifizierte leptinpolypeptide und deren verwendungen
|
BRPI0906388A2
(pt)
*
|
2008-02-08 |
2015-07-07 |
Scripps Research Inst |
Quebra de tolerância imunológica com um aminoácido não natural geneticamente codificado
|
US20110076718A1
(en)
*
|
2008-02-27 |
2011-03-31 |
The Scripps Research Institute |
In vivo incorporation of an unnatural amino acid comprising a 1,2-aminothiol group
|
AU2009251883B2
(en)
|
2008-03-31 |
2014-09-11 |
Pacific Biosciences Of California, Inc. |
Generation of modified polymerases for improved accuracy in single molecule sequencing
|
UA118536C2
(uk)
|
2008-07-23 |
2019-02-11 |
Амбркс, Інк. |
Модифікований поліпептид бичачого гранулоцитарного колонієстимулювального фактора та його застосування
|
MX348657B
(es)
|
2008-09-26 |
2017-06-21 |
Ambrx Inc |
Microorganismos y vacunas dependientes de replicacion de aminoacidos no naturales.
|
EP3216800A1
(de)
|
2008-09-26 |
2017-09-13 |
Ambrx, Inc. |
Modifizierte tierische erythropoietin-polypeptide und deren verwendungen
|
US20090197339A1
(en)
*
|
2008-12-10 |
2009-08-06 |
The Scripps Research Institute |
In vivo unnatural amino acid expression in the methylotrophic yeast pichia pastoris
|
CN102307905B
(zh)
|
2008-12-10 |
2015-11-25 |
斯克利普斯研究院 |
利用化学反应性非天然氨基酸产生载体-肽偶联物
|
NZ600363A
(en)
|
2009-12-21 |
2014-07-25 |
Ambrx Inc |
Modified porcine somatotropin polypeptides and their uses
|
CN102753573A
(zh)
|
2009-12-21 |
2012-10-24 |
Ambrx公司 |
经过修饰的牛促生长素多肽和其用途
|
US8980253B2
(en)
|
2010-04-26 |
2015-03-17 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-tRNA synthetase
|
CN103096911B
(zh)
|
2010-04-27 |
2018-05-29 |
Atyr 医药公司 |
与异亮氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
US8986681B2
(en)
|
2010-04-27 |
2015-03-24 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl-tRNA synthetases
|
AU2011248489B2
(en)
|
2010-04-28 |
2016-10-06 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl tRNA synthetases
|
CN103097523B
(zh)
|
2010-04-29 |
2016-09-28 |
Atyr医药公司 |
与天冬酰胺酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
WO2011150279A2
(en)
|
2010-05-27 |
2011-12-01 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-trna synthetases
|
EP2563383B1
(de)
|
2010-04-29 |
2017-03-01 |
Atyr Pharma, Inc. |
Innovative entdeckung therapeutischer, diagnostischer und antikörperhaltiger zusammensetzungen im zusammenhang mit proteinfragmenten von valyl-trna-synthetasen
|
EP2566496B1
(de)
|
2010-05-03 |
2018-02-28 |
aTyr Pharma, Inc. |
Innovative entdeckung therapeutischer, diagnostischer und antikörperhaltiger zusammensetzungen im zusammenhang mit proteinfragmenten von methionyl-trna-synthetasen
|
US9034321B2
(en)
|
2010-05-03 |
2015-05-19 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases
|
CA2797277C
(en)
|
2010-05-03 |
2021-02-23 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-trna synthetases
|
CN103108655B
(zh)
|
2010-05-03 |
2017-04-05 |
Atyr 医药公司 |
与丝氨酰‑tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
CA2798139C
(en)
|
2010-05-04 |
2019-09-24 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex
|
CA2798301C
(en)
|
2010-05-04 |
2020-09-15 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutamyl-prolyl-trna synthetases
|
CN103200953B
(zh)
|
2010-05-14 |
2017-02-15 |
Atyr 医药公司 |
与苯丙氨酰‑β‑tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
CN103096914B
(zh)
|
2010-05-17 |
2015-08-12 |
Atyr医药公司 |
与亮氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
AU2011261486B2
(en)
|
2010-06-01 |
2017-02-23 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-tRNA synthetases
|
NZ603811A
(en)
|
2010-07-12 |
2015-03-27 |
Atyr Pharma Inc |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-trna synthetases
|
US8999321B2
(en)
|
2010-07-12 |
2015-04-07 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases
|
EP2593125B1
(de)
|
2010-07-12 |
2017-11-01 |
aTyr Pharma, Inc. |
Innovative erkennung therapeutischer, diagnostischer und antikörperhaltiger zusammensetzungen in zusammenhang mit proteinfragmenten von glycyl-trna-synthetasen
|
KR20130102534A
(ko)
|
2010-07-12 |
2013-09-17 |
에이티와이알 파마, 인코포레이티드 |
히스티딜trna 합성효소의 단백질 단편에 관련된 치료적, 진단적, 및 항체 조성물의 혁신적 발견
|
US9567386B2
(en)
|
2010-08-17 |
2017-02-14 |
Ambrx, Inc. |
Therapeutic uses of modified relaxin polypeptides
|
BR112013003522B1
(pt)
|
2010-08-17 |
2021-05-25 |
Ambrx, Inc. |
polipeptídeos relaxina modificados compreendendo um aminoácido não codificado naturalmente, seu método de preparação e seu uso, bem como ácido nucleico e célula hospedeira
|
CN103108650A
(zh)
|
2010-08-25 |
2013-05-15 |
Atyr医药公司 |
与酪氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
TWI480288B
(zh)
|
2010-09-23 |
2015-04-11 |
Lilly Co Eli |
牛顆粒細胞群落刺激因子及其變體之調配物
|
CA2812795C
(en)
|
2010-10-06 |
2021-08-31 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of tryptophanyl trna synthetases
|
US20130078671A1
(en)
*
|
2011-03-25 |
2013-03-28 |
The Texas A&M University System |
Incorporation of two different noncanonical amino acids into a single protein
|
EP3613852A3
(de)
|
2011-07-22 |
2020-04-22 |
President and Fellows of Harvard College |
Beurteilung und verbesserung einer nukleasespaltungsspezifität
|
US9714419B2
(en)
|
2011-08-09 |
2017-07-25 |
Atyr Pharma, Inc. |
PEGylated tyrosyl-tRNA synthetase polypeptides
|
US9816084B2
(en)
|
2011-12-06 |
2017-11-14 |
Atyr Pharma, Inc. |
Aspartyl-tRNA synthetases
|
US9822353B2
(en)
|
2011-12-06 |
2017-11-21 |
Atyr Pharma, Inc. |
PEGylated aspartyl-tRNA synthetase polypeptides
|
CN102517241B
(zh)
*
|
2011-12-19 |
2013-06-19 |
中国药科大学 |
一种含有d型氨基酸的双羰基还原酶的突变体的制备方法
|
CA2858613A1
(en)
|
2011-12-29 |
2013-08-08 |
Atyr Pharma, Inc. |
Aspartyl-trna synthetase-fc conjugates
|
IN2014DN09922A
(de)
*
|
2012-05-18 |
2015-08-14 |
Medical Res Council |
|
UY35368A
(es)
|
2013-03-08 |
2014-10-31 |
Irm Llc |
Péptidos y composiciones para el tratamiento de daño articular
|
AU2014233436B2
(en)
|
2013-03-15 |
2019-12-05 |
Atyr Pharma, Inc. |
Histidyl-tRNA synthetase-Fc conjugates
|
CN104099360A
(zh)
*
|
2013-04-12 |
2014-10-15 |
北京大学 |
非天然氨基酸标记的目的蛋白或肽的制备
|
US10005838B2
(en)
|
2013-07-19 |
2018-06-26 |
The Regents Of The University Of California |
Milk fat globule epidermal growth factor 8 regulates fatty acid uptake
|
US9163284B2
(en)
|
2013-08-09 |
2015-10-20 |
President And Fellows Of Harvard College |
Methods for identifying a target site of a Cas9 nuclease
|
US9359599B2
(en)
|
2013-08-22 |
2016-06-07 |
President And Fellows Of Harvard College |
Engineered transcription activator-like effector (TALE) domains and uses thereof
|
US9322037B2
(en)
|
2013-09-06 |
2016-04-26 |
President And Fellows Of Harvard College |
Cas9-FokI fusion proteins and uses thereof
|
US9737604B2
(en)
|
2013-09-06 |
2017-08-22 |
President And Fellows Of Harvard College |
Use of cationic lipids to deliver CAS9
|
US9228207B2
(en)
|
2013-09-06 |
2016-01-05 |
President And Fellows Of Harvard College |
Switchable gRNAs comprising aptamers
|
US20150166982A1
(en)
|
2013-12-12 |
2015-06-18 |
President And Fellows Of Harvard College |
Methods for correcting pi3k point mutations
|
US10077453B2
(en)
|
2014-07-30 |
2018-09-18 |
President And Fellows Of Harvard College |
CAS9 proteins including ligand-dependent inteins
|
KR20240024362A
(ko)
|
2014-10-24 |
2024-02-23 |
브리스톨-마이어스 스큅 컴퍼니 |
변형된 fgf-21 폴리펩티드 및 그의 용도
|
IL297090A
(en)
|
2015-07-30 |
2022-12-01 |
Macrogenics Inc |
Molecules that bind pd-1 and methods of using them
|
IL294014B1
(en)
|
2015-10-23 |
2024-03-01 |
Harvard College |
Nucleobase editors and their uses
|
TWI758267B
(zh)
|
2015-12-14 |
2022-03-21 |
美商宏觀基因股份有限公司 |
對於pd-1和ctla-4具有免疫反應性的雙特異性分子及其使用方法
|
AU2017306676B2
(en)
|
2016-08-03 |
2024-02-22 |
President And Fellows Of Harvard College |
Adenosine nucleobase editors and uses thereof
|
CA3033327A1
(en)
|
2016-08-09 |
2018-02-15 |
President And Fellows Of Harvard College |
Programmable cas9-recombinase fusion proteins and uses thereof
|
WO2018039438A1
(en)
|
2016-08-24 |
2018-03-01 |
President And Fellows Of Harvard College |
Incorporation of unnatural amino acids into proteins using base editing
|
CN110214180A
(zh)
|
2016-10-14 |
2019-09-06 |
哈佛大学的校长及成员们 |
核碱基编辑器的aav递送
|
KR20190084287A
(ko)
|
2016-11-14 |
2019-07-16 |
노파르티스 아게 |
연골 손상 및 관절염 치료 방법 및 조성물
|
WO2018119359A1
(en)
|
2016-12-23 |
2018-06-28 |
President And Fellows Of Harvard College |
Editing of ccr5 receptor gene to protect against hiv infection
|
CN110637027A
(zh)
|
2017-02-08 |
2019-12-31 |
百时美施贵宝公司 |
包含药代动力学增强子的修饰的松弛素多肽及其用途
|
US11898179B2
(en)
|
2017-03-09 |
2024-02-13 |
President And Fellows Of Harvard College |
Suppression of pain by gene editing
|
JP2020510439A
(ja)
|
2017-03-10 |
2020-04-09 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
シトシンからグアニンへの塩基編集因子
|
KR20190130613A
(ko)
|
2017-03-23 |
2019-11-22 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
핵산 프로그램가능한 dna 결합 단백질을 포함하는 핵염기 편집제
|
JP2020517638A
(ja)
|
2017-04-20 |
2020-06-18 |
エータイアー ファーマ, インコーポレイテッド |
肺の炎症を治療するための組成物および方法
|
WO2018209320A1
(en)
|
2017-05-12 |
2018-11-15 |
President And Fellows Of Harvard College |
Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation
|
WO2019023680A1
(en)
|
2017-07-28 |
2019-01-31 |
President And Fellows Of Harvard College |
METHODS AND COMPOSITIONS FOR EVOLUTION OF BASIC EDITORS USING PHAGE-ASSISTED CONTINUOUS EVOLUTION (PACE)
|
US11319532B2
(en)
|
2017-08-30 |
2022-05-03 |
President And Fellows Of Harvard College |
High efficiency base editors comprising Gam
|
US11795443B2
(en)
|
2017-10-16 |
2023-10-24 |
The Broad Institute, Inc. |
Uses of adenosine base editors
|
WO2019175316A1
(en)
|
2018-03-15 |
2019-09-19 |
Universität Hamburg |
Synthetic transfer rna with extended anticodon loop
|
LU100734B1
(en)
|
2018-03-15 |
2019-10-01 |
Univ Hamburg |
Synthetic transfer RNA with extended anticodon loop
|
KR20200142519A
(ko)
|
2018-03-27 |
2020-12-22 |
에스씨피 홀딩스 언 어숨드 비지니스 네임 오브 나이트라이드 이그나이터스 엘엘씨 |
쿡탑용 고온 표면 점화기
|
MX2020011529A
(es)
|
2018-05-01 |
2021-01-29 |
Ambrx Inc |
Un metodo para optimizar la expresion de anticuerpos.
|
US20220056093A1
(en)
|
2018-09-11 |
2022-02-24 |
Ambrx, Inc. |
Interleukin-2 polypeptide conjugates and their uses
|
EP3867265A1
(de)
|
2018-10-19 |
2021-08-25 |
Ambrx, Inc. |
Interleukin-10 -polypeptid-konjugate, dimere davon und ihre verwendungen
|
CN111718920B
(zh)
*
|
2019-03-19 |
2021-05-07 |
宁波鲲鹏生物科技有限公司 |
在蛋白中高效引入赖氨酸衍生物的氨酰基-tRNA合成酶
|
EP3942040A1
(de)
|
2019-03-19 |
2022-01-26 |
The Broad Institute, Inc. |
Verfahren und zusammensetzungen zur editierung von nukleotidsequenzen
|
EP3953469A1
(de)
|
2019-04-11 |
2022-02-16 |
Arcturus Therapeutics, Inc. |
Synthetische transfer-rns mit verlängerter anticodon-schleife
|
LU101182B1
(en)
*
|
2019-04-11 |
2020-10-12 |
Univ Hamburg |
Synthetic transfer RNA with extended anticodon loop
|
CN110172467B
(zh)
*
|
2019-05-24 |
2021-03-16 |
浙江大学 |
一种利用嵌合设计方法构建正交的氨酰-tRNA合成酶/tRNA体系
|
KR20220151202A
(ko)
|
2020-03-11 |
2022-11-14 |
암브룩스, 인코포레이티드 |
인터류킨-2 폴리펩타이드 접합체 및 그의 사용 방법
|
MX2022014008A
(es)
|
2020-05-08 |
2023-02-09 |
Broad Inst Inc |
Métodos y composiciones para la edición simultánea de ambas cadenas de una secuencia de nucleótidos de doble cadena objetivo.
|
CN114250243B
(zh)
*
|
2020-09-24 |
2024-05-03 |
深圳华大生命科学研究院 |
一种检测极端嗜盐生物中氨酰-tRNA合成酶和tRNA活性的系统及方法
|
EP4366778A1
(de)
|
2021-07-09 |
2024-05-15 |
Bright Peak Therapeutics AG |
Antikörperkonjugate und herstellung davon
|
EP4366782A1
(de)
|
2021-07-09 |
2024-05-15 |
Bright Peak Therapeutics AG |
Konjugate von checkpoint-inhibitoren mit il-2 und verwendungen davon
|
CA3222357A1
(en)
|
2021-07-09 |
2023-01-12 |
Bertolt Kreft |
Modified il-2 polypeptides for treatment of inflammatory and autoimmune diseases
|
CA3222358A1
(en)
|
2021-07-09 |
2023-01-12 |
Vijaya Raghavan PATTABIRAMAN |
Checkpoint inhibitors conjugated to il-2, and uses thereof
|
WO2023281482A1
(en)
|
2021-07-09 |
2023-01-12 |
Bright Peak Therapeutics Ag |
Cd20-targeted il-2 and its uses
|
WO2023069816A2
(en)
|
2021-09-20 |
2023-04-27 |
The Broad Institute, Inc. |
Compositions and methods for multiplex decoding of quadruplet codons
|
WO2023161854A1
(en)
|
2022-02-23 |
2023-08-31 |
Bright Peak Therapeutics Ag |
Immune antigen specific il-18 immunocytokines and uses thereof
|
WO2023161857A1
(en)
|
2022-02-23 |
2023-08-31 |
Bright Peak Therapeutics Ag |
Bifunctional cytokine compositions
|
CN114908066B
(zh)
*
|
2022-05-17 |
2024-01-23 |
杭州嵌化合生医药科技有限公司 |
一种正交翻译系统及其在再分配密码子恢复ptc疾病中功能蛋白表达方面的应用
|
WO2024091824A1
(en)
|
2022-10-26 |
2024-05-02 |
Ada Forsyth Institute, Inc. |
Differentiation and reprogramming of chondrocyte
|
CN115975978B
(zh)
*
|
2023-02-01 |
2023-08-01 |
珠海宝锐生物科技有限公司 |
Bst DNA聚合酶大片段突变体及其应用
|